A second wallet is quietly running the acquisition markets, and Viking is its biggest stake
0xefbb…2e36 holds 70 percent of the Viking Therapeutics buyout market and dominates six markets in all. It is not the GitLab operator.
Polymarket's acquisition sector does not have one house. It has two. The second one holds 70 percent of the Viking Therapeutics market.
On-chain analysis
Of the $622,000 traded on whether Viking Therapeutics gets acquired, one wallet, 0xefbb…2e36, holds $433,551, betting YES. That is 70 percent of the market.
It is not the wallet behind GitLab, Perplexity and Nebius. It is a different operator running the same playbook: dominant positions across six markets, on an account created days before it began trading.
Two operators independently cornering the same sector is the finding worth sitting with. Betting on mergers and acquisitions here is, in practice, a contest among a handful of large, sector-focused actors, not a public consensus.
We name no one. We are showing you that a second wallet, on its own, is most of this market and a recurring force across the others.
Wallet network
Deeper layerBeyond single-wallet metrics: who is actually behind the flow. We group pseudonymous wallets into controlled-entity candidates using observable on-chain signatures, identical trade size, same-day entry, shared side, single-market lifetime.
Drag any node to explore. Hover to trace its links. Click a wallet for its validated on-chain pages.
- This market
- Dominant wallet
- Coordinated ring
On-chain trade-signature linkage + wallet-age + both-sides. Realized PnL not asserted (needs CTF decoder).
Dominant YES wallet
High confidence- a single address holds 69.7% of all market volume
- 26 trades
Show 1 sample wallet
Coverage & limits: On-chain trade-signature linkage + wallet-age + both-sides. Realized PnL not asserted (needs CTF decoder).
Wallet risk
Cross-marketEach controlling wallet scored across all of its Polymarket activity: ring membership, concentration, wallet freshness, and cross-market footprint, with market-makers down-weighted. Higher is more insider-like.
Signals exposed
concentration=69.7%participant_risk=44/100Wallets that drove the risk
Open-ended resolution.
“Resolves YES if Viking Therapeutics is acquired before January 1, 2027, per credible reporting.”
Every figure is read from on-chain Polygon trade logs for this market and from BlackHart's BRI-PM v0.2 scorer. Polymarket system contracts are excluded from every wallet figure. Entity and wallet-risk groupings are statistical inferences from observable on-chain signatures.
The BlackHart extension overlays this risk score directly on Polymarket, so you see the signal before you place the trade.